DRKS00011111
Completed
未知
Development and Evaluation of a cognitive behavioral therapy program as prophylactic treatment of migraine in adults - Mainz Migraine Trail
Psychologisches Institut; Johannes Gutenberg-Universität Mainz0 sites121 target enrollmentSeptember 27, 2016
ConditionsDSM-IV-Diagnosis (307.89): Pain Disorder Associated With Both Psychological Factors and a General Medical Condition DSM-IV-Diagnosis (316): Specified Psychological Factor Affecting MigraineDSM-5-Diagnosis (F45.1): somatic symptom disorder, with predominant painDSM-5 Diagnosis (F54): Psychological factors affecting other medical conditions (migraine)G43Migraine
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- DSM-IV-Diagnosis (307.89): Pain Disorder Associated With Both Psychological Factors and a General Medical Condition DSM-IV-Diagnosis (316): Specified Psychological Factor Affecting MigraineDSM-5-Diagnosis (F45.1): somatic symptom disorder, with predominant painDSM-5 Diagnosis (F54): Psychological factors affecting other medical conditions (migraine)
- Sponsor
- Psychologisches Institut; Johannes Gutenberg-Universität Mainz
- Enrollment
- 121
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(i) diagnosed as either migraine without aura”, migraine with aura”, or chronic migraine” (according to ICHD\-3 beta) ;
- •(ii) minimum of 4 headache days per month, minimum migraine chronicity of 12 month, and pattern of migraine symptoms stable over last 6 months;
- •(iii) psychological factors such as dysfunctional thoughts, emotions, behaviors are associated with migraine (i.e. DSM\-IV diagnosis 307\.89 or 316 or DSM\-5 diagnosis F45\.1 or F54\);
- •(iv) sufficient language ability (German language) and internet access
Exclusion Criteria
- •(i) diagnosis of Medication\-Overuse\-Headache (according to ICHD\-3 beta);
- •(ii) currently taking headache prophylactic medication (3\-month wash\-out) or therapy with botulinum toxin or neuromodulation during trial period;
- •(iii) completed or current psychotherapy;
- •(iv) substantial medical or psychiatric comorbidities that are deemed likely to interfere with the ability to participate in treatment;
- •(v) suicidal tendency;
- •(vi) pregnant, planning pregnancy during trial period or lactating
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Development and Evaluation of a cognitive behavioral therapy program as prophylactic treatment of migraine in adults - Pilot study of Mainz Migraine TrailDSM-IV (307.89): Pain Disorder Associated With Both Psychological Factors and a General Medical ConditionDSM-IV (316): Specified Psychological Factor Affecting MigraineDSM-5 (F45.1): Somatic Symptom Disorder with Predominant PainDSM-5 (54): Psychological Factor Affecting MigraineG43MigraineDRKS00011143Psychologisches Institut,Johannes-Gutenberg Universität Mainz10
Completed
Not Applicable
Effects of mHealth-based self-management education program for patients with rheumatoid arthritisDiseases of the musculoskeletal system and connective tissueKCT0007523Ajou University166
Completed
Not Applicable
Cognitive Behavioural Therapy for Vestibular MigraineVestibular migraineDepressionAnxietyNeurological - Other neurological disordersMental Health - DepressionMental Health - AnxietyACTRN12611001086954Royal Prince Alfred Hospital70
Active, not recruiting
Not Applicable
The impact of cognitive behavioural therapy delivered by GPs and nurses on sleep qualityInsomniaMental and Behavioural DisordersISRCTN10144646Management Primary care Majorca134
Completed
Not Applicable
The Effectiveness of Cognitive-Behavioral Group Counseling on Premenopausal Women's AnxietyAnxiety.Organic anxiety disorderIRCT20170826035896N2Shahroud University of Medical Sciences60